Bank Of America Corp Ani Pharmaceuticals Inc Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of America Corp holds 25,664 shares of ANIP stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,664

Previous 12,339 107.99%

Holding current value

$1.55 Million

Previous $852,000 91.78%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$58.53 - $68.82 $779,912 - $917,026	13,325 Added 107.99%	25,664 $1.63 Million
Q1 2024 May 15, 2024	SELL	$54.2 - $69.69 $717,770 - $922,904	-13,243 Reduced 51.77%	12,339 $852,000
Q4 2023 Feb 14, 2024	BUY	$48.72 - $65.43 $269,372 - $361,762	5,529 Added 27.57%	25,582 $1.41 Million
Q2 2023 Aug 14, 2023	SELL	$37.29 - $53.83 $193,162 - $278,839	-5,180 Reduced 20.53%	20,053 $1.08 Million
Q1 2023 May 12, 2023	SELL	$37.61 - $45.72 $112 - $137	-3 Reduced 0.01%	25,233 $1 Million
Q4 2022 Feb 10, 2023	BUY	$31.9 - $41.95 $294,915 - $387,827	9,245 Added 57.81%	25,236 $1.02 Million
Q3 2022 Nov 14, 2022	SELL	$29.83 - $38.01 $55,036 - $70,128	-1,845 Reduced 10.34%	15,991 $514,000
Q2 2022 Aug 12, 2022	BUY	$23.09 - $33.46 $130,181 - $188,647	5,638 Added 46.22%	17,836 $529,000
Q1 2022 May 16, 2022	BUY	$26.91 - $47.15 $66,333 - $116,224	2,465 Added 25.33%	12,198 $343,000
Q4 2021 Feb 08, 2022	SELL	$32.97 - $56.85 $157,200 - $271,060	-4,768 Reduced 32.88%	9,733 $448,000
Q3 2021 Nov 15, 2021	BUY	$26.48 - $35.99 $179,746 - $244,300	6,788 Added 88.01%	14,501 $476,000
Q2 2021 Sep 13, 2021	BUY	$31.86 - $38.6 $245,736 - $297,721	7,713 New	7,713 $270,000

Others Institutions Holding ANIP

# of Institutions

206

Shares Held

15M

Call Options Held

24K

Put Options Held

7.7K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.05B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Ani Pharmaceuticals Inc Transaction History